Forecast & Rating3 analysts currently cover Moleculin Biotech, of which 3 give a positive rating. The average price target is $21.00, about 5150.0% upside from the current price of $0.40. Coverage is limited, so the data is for reference only. Data as of Aug 2, 2026; this does not constitute investment advice.
Jul 31, 2026
Price forecast
$21.005150.00%
Forecast & RatingStrong buy
3analysts
Strong buy66.67%
Buy33.33%
Hold0.00%
Sell0.00%
Strong sell0.00%
Strong buy
2
Buy
1
Hold
0
Sell
0
Strong sell
0
Target price forecast
Forecast baselineJul 26, 2026
Forecast met0.0%
Stock price$0.40
Average forecast price$24.3
Highest forecast price$31
Lowest forecast price$20
Average forecast price
$24.3
Highest forecast price
$31
Lowest forecast price
$20
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.